Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Sinobiopharma Prospers on Muscle Relaxant Drug

publication date: Jan 30, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinobiopharma, Inc. reported much improved results from its wholly owned (and only) operating subsidiary, Dong Ying China, for the six-month period ended November 30, 2008. The most positive item in the report was the company’s revenues, which jumped 220% to $1.9 million. Almost all of the company’s sales came from Cisatracurium Besylate, a skeletal muscle relaxant, which contributed $1.8 million to Sinobiopharma’s coffers. More details...

Stock Symbol: (OTCBB: SNBP)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners